1504 related articles for article (PubMed ID: 33525632)
1. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
Wong NA; Saier MH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
[TBL] [Abstract][Full Text] [Related]
2. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
3. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
Noor R
Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
[TBL] [Abstract][Full Text] [Related]
4. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.
Yoshimoto FK
Protein J; 2020 Jun; 39(3):198-216. PubMed ID: 32447571
[TBL] [Abstract][Full Text] [Related]
5. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
6. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
7. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.
Ortiz-Prado E; Simbaña-Rivera K; Gómez-Barreno L; Rubio-Neira M; Guaman LP; Kyriakidis NC; Muslin C; Jaramillo AMG; Barba-Ostria C; Cevallos-Robalino D; Sanches-SanMiguel H; Unigarro L; Zalakeviciute R; Gadian N; López-Cortés A
Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115094. PubMed ID: 32623267
[TBL] [Abstract][Full Text] [Related]
8. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
Bartoszewski R; Dabrowski M; Jakiela B; Matalon S; Harrod KS; Sanak M; Collawn JF
Am J Physiol Lung Cell Mol Physiol; 2020 Sep; 319(3):L444-L455. PubMed ID: 32755307
[TBL] [Abstract][Full Text] [Related]
10. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
11. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
Fung TS; Liu DX
Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
[TBL] [Abstract][Full Text] [Related]
12. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
13. Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
Han Y; Yuan Z; Yi Z
J Virol; 2024 May; 98(5):e0034924. PubMed ID: 38639488
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection.
Comar CE; Goldstein SA; Li Y; Yount B; Baric RS; Weiss SR
mBio; 2019 Mar; 10(2):. PubMed ID: 30914508
[TBL] [Abstract][Full Text] [Related]
15. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
Prompetchara E; Ketloy C; Palaga T
Asian Pac J Allergy Immunol; 2020 Mar; 38(1):1-9. PubMed ID: 32105090
[TBL] [Abstract][Full Text] [Related]
16. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
Davies JP; Almasy KM; McDonald EF; Plate L
ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
[TBL] [Abstract][Full Text] [Related]
17. The current landscape of coronavirus-host protein-protein interactions.
Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO
J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513
[TBL] [Abstract][Full Text] [Related]
18. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
[TBL] [Abstract][Full Text] [Related]
20. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.
Kehrer T; García-Sastre A; Miorin L
J Interferon Cytokine Res; 2021 Jun; 41(6):205-219. PubMed ID: 34161170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
